About MLG Support

This author has not yet filled in any details.
So far MLG Support has created 78 blog entries.

Marbury Law Again Ranked in Top Ten By PatentBots for 2022

Marbury Law Group was once again ranked in the top ten for PatentBots’ quality scores for U.S. Patent and Trademark Office Technology Center 2800 (Semiconductors/Memory, Circuit/Measuring and Testing, Optics/Photocopying, Printing/Measuring and Testing). Patent Bots Automated Proofreading and Examiner Statistics Blog

2022-09-02T11:51:53-05:00September 2, 2022|Firm News|

Sunday, September 18th, 2022 – “The Teva Petition for Certiorari in GSK v. Teva, the COREG® case” discussion

Marbury Partner Michelle E. O’Brien will discuss the latest updates on “The Teva Petition for Certiorari in GSK v. Teva, the COREG® case” at IPO’s Annual Meeting in Los Angeles, CA on September 18, 2022.

2022-09-02T00:33:56-05:00September 2, 2022|Firm News|

Thursday, August 4, 2022 – “The Teva Petition for Certiorari in GSK v. Teva, the COREG® case”

Marbury partner Michelle E. O'Brien will co-present "The Teva Petition for Certiorari in GSK v. Teva, the COREG® case" at IPO's Pharma/Bio Monthly Meeting on August 4, 2022.

2022-08-03T16:24:06-05:00August 2, 2022|Firm News|

USPTO Announces Plans for PTAB In-Person Hearings

The U.S. Patent Office announces plans to re-establish the option of having in-person hearings at the United States Patent and Trademark Office (USPTO) headquarters in Alexandria, VA, and at all regional offices: https://www.uspto.gov/subscription-center/2022/person-ptab-hearings-resume-uspto

2022-09-02T00:50:16-05:00June 17, 2022|Uncategorized|

Kansas State Bar Association’s 2022 Intellectual Property Institute “Patent Year in Review” – Friday June 3, 2022

Marbury Partner Michelle E. O’Brien will be joining an expert panel of patent practitioners at the Kansas State Bar Association’s 2022 Intellectual Property Institute on Friday, June 3, 2022.  The panel, “Patent Year in Review,” will discuss the impact of recent important decisions by the U.S. Supreme Court, Court of Appeals for the Federal Circuit, and U.S. [...]

2022-06-02T16:05:34-05:00June 2, 2022|Firm News|

Friday, May 20, 2022 – Advanced Chemical/Pharma Patent Practice Institute: A Post Doc Bootcamp

Marbury Partner Michelle E. O’Brien will be joining a distinguished group of experienced chemical and pharmaceutical patent practitioners at the Advanced Chemical/Pharma Patent Practice Institute: A Post Doc Bootcamp on Friday, May 20, 2022, following the close of the AIPLA Spring Meeting.  Michelle and her colleagues will present an interactive, 3 hour program focused on [...]

2022-04-19T17:33:59-05:00April 18, 2022|Firm News|

Tuesday, May 17, 2022 – Chemical Patent Language Workshop: The Global Quest for Reasonable Certainty

Marbury Partner Michelle E. O’Brien will be joining an expert panel of patent practitioners at AIPLA’s Spring Meeting on Tuesday, May 17, 2022, to discuss Chemical Patent Language Workshop: The Global Quest for Reasonable Certainty.  The panel will consider various claim language and discuss how it has been or may be construed by courts, with [...]

2022-04-19T17:33:30-05:00April 18, 2022|Firm News|

Marbury Law Ranked in the Top Ten for PatentBots Quality Scores

Marbury Law ranked in the Top Ten of this year’s PatentBots’ quality scores for U.S. Patent and Trademark Office Technology Center 2800.  The ranking was based on a review of 284 firms with at least 50 issued patents in the areas examined by Technology Center 2800 (Semiconductors/Memory, Circuit/Measuring and Testing, Optics/Photocopying, Printing/Measuring and Testing). https://www.patentbots.com/firms/2800

2020-06-09T13:10:55-05:00June 9, 2020|Firm News, Uncategorized|

101 In The Summer of 2019

Speaking at the 16th Annual World Congress Summit on Protecting Innovations in the Financial Services Industry in July, U.S. Patent and Trademark Office Director Andrei Iancu said that the agency’s new guidance to examiners on patent subject matter eligibility under Section 101 is “working really well” and resulting in fewer eligibility rejections.  That guidance can [...]

2019-08-30T12:20:45-05:00August 30, 2019|Uncategorized|
Go to Top